Arcutis Biotherapeutics (NASDAQ:ARQT) Issues Quarterly Earnings Results, Beats Expectations By $0.09 EPS
Arcutis Biotherapeutics (NASDAQ:ARQT – Get Free Report) announced its earnings results on Wednesday. The company reported ($0.33) EPS for the quarter, beating analysts’ consensus estimates of ($0.42) by $0.09, Zacks reports. The business had revenue of $44.76 million during the quarter, compared to analysts’ expectations of $38.05 million. Arcutis Biotherapeutics had a negative net margin […]
More Stories
Shanghai Industrial (OTCMKTS:SGHIY) Hits New 12-Month High – Should You Buy?
Shanghai Industrial Holdings Limited (OTCMKTS:SGHIY – Get Free Report)’s stock price hit a new 52-week high on Monday . The...
Napco Security Technologies (NASDAQ:NSSC) Downgraded to Sell Rating by StockNews.com
Napco Security Technologies (NASDAQ:NSSC – Get Free Report) was downgraded by investment analysts at StockNews.com from a “hold” rating to...
StockNews.com Downgrades Virtus Investment Partners (NASDAQ:VRTS) to Hold
Virtus Investment Partners (NASDAQ:VRTS – Get Free Report) was downgraded by analysts at StockNews.com from a “buy” rating to a...
Alarm.com (NASDAQ:ALRM) Upgraded by StockNews.com to “Buy” Rating
Alarm.com (NASDAQ:ALRM – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “hold” rating to a...
Eastman Chemical (NYSE:EMN) Downgraded by StockNews.com to Hold
Eastman Chemical (NYSE:EMN – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a...
Telefônica Brasil (NYSE:VIV) Cut to Buy at StockNews.com
Telefônica Brasil (NYSE:VIV – Get Free Report) was downgraded by analysts at StockNews.com from a “strong-buy” rating to a “buy”...